Corcept Therapeutics Inc [CORT] stock prices are up 3.31% to $80.28 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CORT shares have gain 6.88% over the last week, with a monthly amount glided 10.64%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Truist upgraded its rating to Buy on November 06, 2023, and elevated its price target to $38. On April 11, 2023, SVB Securities initiated with a Market Perform rating and assigned a price target of $25 on the stock. Piper Sandler started tracking the stock assigning an Overweight rating and suggested a price target of $27 on April 04, 2023. Jefferies downgraded its rating to a Hold and reduced its price target to $22 on February 15, 2023. Truist downgraded its rating to Hold for this stock on August 01, 2022, but kept the price target unchanged to $30. In a note dated July 27, 2022, Jefferies upgraded a Buy rating on this stock and boosted its target price from $21 to $35.
The stock price of Corcept Therapeutics Inc [CORT] has been fluctuating between $49.00 and $117.33 over the past year. Currently, Wall Street analysts expect the stock to reach $140 within the next 12 months. Corcept Therapeutics Inc [NASDAQ: CORT] shares were valued at $80.28 at the most recent close of the market. An investor can expect a potential return of 74.39% based on the average CORT price forecast.
Analyzing the CORT fundamentals
The Corcept Therapeutics Inc [NASDAQ:CORT] reported sales of 741.17M for trailing twelve months, representing a surge of 13.75%. Gross Profit Margin for this corporation currently stands at 0.98% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.13, Equity is 0.16 and Total Capital is 0.1. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 78.65 points at the first support level, and at 77.01 for the second support level. However, for the 1st resistance point, the stock is sitting at 81.66, and for the 2nd resistance point, it is at 83.04.
Ratios To Look Out For
It’s worth pointing out that Corcept Therapeutics Inc [NASDAQ:CORT]’s Current Ratio is 3.14. Further, the Quick Ratio stands at 3.07, while the Cash Ratio is 0.73. Considering the valuation of this stock, the price to sales ratio is 11.39, the price to book ratio is 13.36 and price to earnings (TTM) ratio is 91.73.
Transactions by insiders
Recent insider trading involved Guyer William, Officer, that happened on Nov 25 ’25 when 4500.0 shares were purchased. Chief Development Officer, Guyer William completed a deal on Nov 05 ’25 to sell 20000.0 shares. Meanwhile, Lyon Joseph Douglas sold 5000.0 shares on Nov 03 ’25.
